LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Stillbirth and neonatal mortality in a subsequent pregnancy following stillbirth: a population-based cohort study.

    Nijkamp, Janna W / Ravelli, Anita C J / Groen, Henk / Erwich, Jan Jaap H M / Mol, Ben Willem J

    BMC pregnancy and childbirth

    2022  Volume 22, Issue 1, Page(s) 11

    Abstract: Background: A history of stillbirth is a risk factor for recurrent fetal death in a subsequent pregnancy. Reported risks of recurrent fetal death are often not stratified by gestational age. In subsequent pregnancies increased rates of medical ... ...

    Abstract Background: A history of stillbirth is a risk factor for recurrent fetal death in a subsequent pregnancy. Reported risks of recurrent fetal death are often not stratified by gestational age. In subsequent pregnancies increased rates of medical interventions are reported without evidence of perinatal benefit. The aim of this study was to estimate gestational-age specific risks of recurrent stillbirth and to evaluate the effect of obstetrical management on perinatal outcome after previous stillbirth.
    Methods: A retrospective cohort study in the Netherlands was designed that included 252.827 women with two consecutive singleton pregnancies (1
    Results: Of 252.827 first pregnancies, 2.058 pregnancies ended in a stillbirth (8.1 per 1000). After adjusting for confounding factors, women with a prior stillbirth have a two-fold higher risk of recurrence (aOR 1.96, 95% CI 1.07-3.60) compared to women with a live birth in their first pregnancy. The highest risk of recurrence occurred in the group of women with a stillbirth in early gestation between 22 and 28 weeks of gestation (a OR 2.25, 95% CI 0.62-8.15), while after 32 weeks the risk decreased. The risk of neonatal death after 34 weeks of gestation is higher in women with a history of stillbirth (aOR 6.48, 95% CI 2.61-16.1) and the risk of neonatal death increases with expectant obstetric management (aOR 10.0, 95% CI 2.43-41.1).
    Conclusions: A history of stillbirth remains an important risk for recurrent stillbirth especially in early gestation (22-28 weeks). Women with a previous stillbirth should be counselled for elective induction in the subsequent pregnancy at 37-38 weeks of gestation to decrease the risk of perinatal death.
    MeSH term(s) Adult ; Cohort Studies ; Delivery, Obstetric/statistics & numerical data ; Female ; Gestational Age ; Humans ; Netherlands/epidemiology ; Pregnancy ; Recurrence ; Retrospective Studies ; Risk ; Stillbirth/epidemiology
    Language English
    Publishing date 2022-01-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2059869-5
    ISSN 1471-2393 ; 1471-2393
    ISSN (online) 1471-2393
    ISSN 1471-2393
    DOI 10.1186/s12884-021-04355-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Safety of Antenatal Predniso(lo)ne and Dexamethasone on Fetal, Neonatal and Childhood Outcomes: A Systematic Review.

    Slob, Elise M A / Termote, Jacqueline U M / Nijkamp, Janna W / van der Kamp, Hetty J / van den Akker, Erica L T

    The Journal of clinical endocrinology and metabolism

    2023  Volume 109, Issue 4, Page(s) e1328–e1335

    Abstract: Context: Due to ethical considerations, antenatal dose finding for prednisolone and dexamethasone in pregnant women is limited, leading to a knowledge gap.: Objective: In order to guide the clinician in weighing benefits vs risks, the aim is to ... ...

    Abstract Context: Due to ethical considerations, antenatal dose finding for prednisolone and dexamethasone in pregnant women is limited, leading to a knowledge gap.
    Objective: In order to guide the clinician in weighing benefits vs risks, the aim is to systematically review the current literature on the side effects of antenatal predniso(lo)ne and dexamethasone use on the fetus, newborn, and (pre)pubertal child.
    Evidence acquisition: The search was performed in PubMed/MEDLINE and Embase using prespecified keywords and Medical Subject Headings. This systematic review investigated studies published until August 2022, with the following inclusion criteria: studies were conducted in humans and assessed side effects of long-term antenatal predniso(lo)ne and dexamethasone use during at least one of the trimesters on the child during the fetal period, neonatal phase, and during childhood.
    Evidence synthesis: In total, 328 papers in PubMed and 193 in Embase were identified. Fifteen studies were eligible for inclusion. Seven records were added through references. Antenatal predniso(lo)ne use may be associated with lower gestational age, but was not associated with miscarriages and stillbirths, congenital abnormalities, differences in blood pressure or low blood glucose levels at birth, or with low bone mass, long-term elevated cortisol and cortisone, or high blood pressure at prepubertal age. Increased risks of antenatal dexamethasone use include association with miscarriages and stillbirths, and from age 16 years, associations with disturbed insulin secretion and higher glucose and cholesterol levels.
    Conclusions: Based on the limited evidence found, predniso(lo)ne may have less side effects compared with dexamethasone in short- and long-term outcomes. Current literature shows minimal risk of side effects in the newborn from administration of a prenatal predniso(lo)ne dose of up to 10 mg per day.
    MeSH term(s) Infant, Newborn ; Child ; Pregnancy ; Female ; Humans ; Adolescent ; Stillbirth ; Abortion, Spontaneous ; Prenatal Care ; Dexamethasone/adverse effects ; Fetus
    Chemical Substances Dexamethasone (7S5I7G3JQL)
    Language English
    Publishing date 2023-09-14
    Publishing country United States
    Document type Systematic Review ; Journal Article
    ZDB-ID 3029-6
    ISSN 1945-7197 ; 0021-972X
    ISSN (online) 1945-7197
    ISSN 0021-972X
    DOI 10.1210/clinem/dgad547
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Thyroid function testing in women who had a stillbirth.

    Nijkamp, Janna W / Korteweg, Fleurisca J / Groen, Henk / Timmer, Albertus / Van Den Berg, Gerrit / Bossuyt, Patrick M / Mol, Ben Willem J / Erwich, Jan Jaap H M

    Clinical endocrinology

    2016  Volume 85, Issue 2, Page(s) 291–298

    Abstract: Context: Thyroid dysfunction is thought to be associated with stillbirth. Therefore, thyroid function is often recommended in the diagnostic investigations for stillbirth.: Objective: We aimed to evaluate the added value of thyroid function testing ... ...

    Abstract Context: Thyroid dysfunction is thought to be associated with stillbirth. Therefore, thyroid function is often recommended in the diagnostic investigations for stillbirth.
    Objective: We aimed to evaluate the added value of thyroid function testing in the diagnostic investigations for stillbirth.
    Design and patients: A nationwide multicentre prospective cohort study in 1025 women who suffered stillbirth >20 weeks of gestation performed between 2002 and 2008. In each woman, an extensive diagnostic work-up was performed, including placental examination and autopsy. TSH and FT4 values below the 2·5th percentile or above the 97·5th percentile according local laboratory reference values were regarded as abnormal. Women with a history of thyroid disease were evaluated separately.
    Main outcome measures: Thyroid function abnormalities in women with stillbirth.
    Results: Of 1025 included women, 21 had a history of thyroid disease (2%). In the 875 with TSH and FT4 results and no history of thyroid disease, 10% had hypothyroxinemia, 4·6% subclinical hypothyroidism, 1·6% overt hypothyroidism and 1·5% subclinical hyperthyroidism. Women with a subclinical hyperthyroidism more often had a foetal death caused by foetal hydrops: 23% vs 2·9% (adjusted OR 10·3, 95% CI 2·5-42).
    Conclusions: Women with a stillbirth had a slightly higher prevalence of overt hypothyroidism, subclinical hypothyroidism and hypothyroxinaemia compared to previous studies on thyroid dysfunction in pregnant women. Given the absence of a strong associations with the cause of stillbirth, and no demonstrated beneficial effects of treating thyroid dysfunction in these women, routine screening after stillbirth is not justified.
    MeSH term(s) Adult ; Cohort Studies ; Female ; Humans ; Hyperthyroidism ; Hypothyroidism ; Netherlands ; Pregnancy ; Pregnancy Complications/diagnosis ; Prospective Studies ; Stillbirth ; Thyroid Function Tests/statistics & numerical data ; Thyrotropin/blood ; Thyroxine/blood ; Young Adult
    Chemical Substances Thyrotropin (9002-71-5) ; Thyroxine (Q51BO43MG4)
    Language English
    Publishing date 2016-01-29
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 121745-8
    ISSN 1365-2265 ; 0300-0664
    ISSN (online) 1365-2265
    ISSN 0300-0664
    DOI 10.1111/cen.13002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top